Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesDialysis
You have accessRestricted Access

Paradoxical Embolism after Declotting of Hemodialysis Fistulae/Grafts in Patients with Patent Foramen Ovale

Steven Wu, Iftikhar Ahmad, Sohail Qayyum, Stephan Wicky and Sanjeeva P. Kalva
CJASN June 2011, 6 (6) 1333-1336; DOI: https://doi.org/10.2215/CJN.09851110
Steven Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iftikhar Ahmad
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sohail Qayyum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Wicky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjeeva P. Kalva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives The safety of percutaneous endovascular declotting procedures for thrombosed hemodialysis fistulae/grafts is well described in the general population; however, its safety in the presence of a patent foramen ovale (PFO) is not known. The objective of this study is to assess the incidence of symptomatic paradoxical embolic events associated with declotting procedure of thrombosed arteriovenous (AV) graft or fistula in patients with documented PFO.

Design, setting, participants, & measurements This was a retrospective study in a hospital-based, academic practice. It included 23 patients (10 men; mean age, 65) with PFO and thrombosed hemodialysis graft/fistula who underwent a standardized declotting procedure with 2 mg of Alteplase and balloon thrombectomy. Twenty patients (87%) had AV grafts, and three (13%) had AV fistulae. The PFO shunt was right to left in two (9%), left to right in eight (34%), and bidirectional in ten (44%). The shunt direction was not specified in three patients (13%). The technical success of the declotting procedure and the frequency of clinically manifested paradoxical embolic events in this patient population were calculated.

Results Fifty declotting procedures were performed on 23 patients with a technical success rate of 96% (48 of 50, 96%). No symptomatic paradoxical embolic events were found in any of the 23 patients with PFO.

Conclusions Symptomatic paradoxical embolic events after percutaneous endovascular declotting procedures of thrombosed AV grafts and fistulae in patients with documented PFO are rare. This procedure appears to be safe in patients with a PFO.

Introduction

A functioning arteriovenous access is critical for patients with ESRD who receive hemodialysis. These arteriovenous accesses are predominantly arteriovenous fistulae (AVF) or arteriovenous grafts (AVG), collectively referred as AVFG in this manuscript, although a few patients are served with long term hemodialysis catheters (1). Often, the AVFG are complicated by outflow obstruction and thrombosis (2). Current data support the use of percutaneous endovascular techniques to restore patency of the AVFG (3). A percutaneous declotting procedure refers to endovascular thrombectomy of the AVFG using mechanical devices (such as balloons or suction catheters) either with or without concurrent use of thrombolytic agents. During this procedure, the thrombus in the AVFG and outflow veins is often pushed into the central veins. This may result in subclinical pulmonary embolism (PE), although symptomatic PE is occasionally reported (4,5). Many reports have established the safety of this procedure in the general population with no documented cardiac septal defects (4,5). However, the safety of this procedure in patients with documented patent foramen ovale (PFO) is not known. Patients with PFO are at risk of paradoxical embolism, and a few studies have reported occurrence of stroke in these patients, especially after a transient increase in the right heart pressures (6–8). Given the high incidence of subclinical PE during declotting of thrombosed AVFG and consequent elevated right heart pressures, there is real concern of paradoxical embolism in patients with PFO. In this study, we seek to assess the incidence of symptomatic paradoxical embolic events after percutaneous endovascular declotting of thrombosed AVFG in patients with documented PFO.

Materials and Methods

This retrospective study was approved by the institutional review board, and the requirement to obtain the informed consent was waived. The study was Health Insurance Portability and Accountability Act compliant. Patients who underwent a percutaneous endovascular declotting procedure for a thrombosed AVFG between January 2003 and December 2008 and had a documented PFO were included in this study. Our interventional database (HI-IQ software, ConexSys, RI) was interrogated to identify patients who had a declotting procedure during this period. The electronic medical records were reviewed for the presence of PFO. Only patients who had PFO on a contrast-enhanced echocardiography were included in this study.

Patients

During the study period (January 2003 to December 2008), 484 percutaneous endovascular declotting procedures were performed on 238 patients. An echocardiogram was available in 171 patients, and 23 (23 of 171, 13.4%) patients had PFO. These patients constituted our study population. There were 10 men and 13 women with an average age of 65 years. Twenty patients (20 of 23, 87%) had AVG, and three (three of 23, 13%) had AVF. The location of the AVF and AVG in these 23 patients is as follows. Three patients had AVFs: two had (two of 23, 9%) radiocephalic fistulae, and one (one of 23, 4%) had a brachiocepalic fistula. Twenty patients had AVGs: three (three of 23; 13%) had radiocephalic grafts; seven (seven of 23; 30%) had brachiocephalic grafts; three (three of 23, 13%) had brachiobasilic grafts; four (four of 20, 17%) had brachioaxillary grafts; and three patients (three of 23, 13%) had grafts at other locations. A total of 50 declotting procedures were performed in these 23 patients (average of 2.2 procedures/patient) during the study period (Table 1 and Fig. 1).

View this table:
  • View inline
  • View popup
Table 1.

Clinical characteristics of 23 patients with PFO

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Selection of the study population.

Echocardiography

Echocardiography was retrieved from our electronic medical records, and the report was reviewed. The results of echocardiography were recorded for direction of flow across the PFO. This assessment was made on color Doppler study in 14 (14 of 23, 60%), agitated saline bubble study in seven (seven of 23, 30%), and on both methods in two (two of 23, 10%). The shunt was right to left in two (two of 23, 9%), left to right in eight (eight of 23, 34%), and bidirectional in ten (ten of 23, 44%). The shunt direction was not specified in three (three of 23, 13%) (Table 2).

View this table:
  • View inline
  • View popup
Table 2.

Shunting patterns of 23 patients with PFO

Percutaneous Endovascular Declotting Procedure

In all of the patients, the declotting procedure was performed using a standard technique. After obtaining an informed consent from the patient, the AVG or AVF was accessed at the arterial end with the needle directed toward the outflow with an 18-G angiocath, and 2 mg of alteplase and 2000 units of heparin were injected. After 1 hour, the patient was brought to an angiosuite, and the AVG- or AVF-bearing arm was prepped and draped. The angiocath was exchanged for a 7Fr sheath over a glide wire. A 5Fr Kumpe catheter was advanced in to the subclavian vein, and venography was performed to assess the patency of the central veins. Angioplasty of the venous outflow stenoses, if any, was performed using appropriately sized balloons. Then the thrombus was pushed in to the central veins with angioplasty balloon. Next, the venous end of the AVG/AVF was accessed, and a 6Fr sheath was placed. A 0.035-inch glide wire was inserted and passed through the arterial anastomosis in to the artery. The thrombus plug at the anastomosis was removed using a 5.5Fr Fogarty balloon. Angioplasty of the arterial anastomosis was performed if a stenosis was identified. The declotting procedure was considered technically successful with return of thrill in the graft or fistula. The sheaths were removed, and hemostasis was achieved through purse-string sutures. As per the department protocol for patients with a PFO, a detailed neurologic examination was performed by a board-certified physician for assessment of stroke after every declotting procedure. The presence of any neurologic deficit was recorded and followed with a neurology consult. If there were no neurologic deficits, the patient was discharged from the hospital. All of the patients were informed about the risk of stroke and were requested to go to the hospital emergency room if symptoms of stroke developed after leaving the hospital.

Data Collection

The data were collected from the medical and imaging regards. Paradoxical embolic events such as stroke, myocardial infarction, limb ischemia, visceral ischemia, etc., were recorded if they occurred within 48 hours of the declotting procedure. If a patient had any imaging study (such computed tomography or magnetic resonance imaging) for ischemic symptoms, the results were reviewed, and the findings were recorded.

Statistical Analyses

The technical success of the declotting procedure in this patient population was calculated. This was compared with the technical success of the declotting procedure for all comers in our division (484 procedures in 238 patients during this time). The frequency of paradoxical embolic events in this population was calculated.

Results

As mentioned earlier, 23 patients with PFO underwent 50 declotting procedures during the period of study. Forty-eight (48 of 50, 96%; 95% confidence interval [CI], 91.12% to 99.98%) declotting procedures were successful. Two declotting procedures, one in a patient with an AVF and another in a patient with an AVG, were unsuccessful. In comparison, the technical success of all of the declotting procedures during this period was 97% (471 of 484 procedures in 238 patients; 95% CI, 95.87% to 98.75%).

There were no symptomatic paradoxical embolic events (0%; 95% CI, 0% to 7.1%) after the declotting procedure in any of the patients with PFO. No patients had imaging studies within 48 hours of a declotting procedure. No patients succumbed to death within this period (48-hour mortality, 0%).

Discussion

With the increasing prevalence of ESRD and the consequent rise in hemodialysis, maintenance of a proper vascular access through AVF or AVG has assumed a great importance (9). AVF and AVG are often complicated with recurrent venous stenosis and thrombosis and necessitate frequent interventions through angioplasty and thrombolysis (3,10). Endovascular recanalization procedures are often complicated by bleeding, vein rupture, PE, and downstream arterial embolization (11). The volume of thrombus during declotting procedures is relatively high, although it is still small compared with the large size of the pulmonary arterial bed (5). Subclinical PE during declotting procedures is common, but symptomatic PE is rare (4). One study reported 35% incidence of PE on perfusion scintigraphy after endovascular declotting of thrombosed AVG and AVF, although only 4% were symptomatic (12). Clinical and subclinical PE result in elevation of pulmonary artery and right heart pressures, although such changes rarely lead to cardiopulmonary compromise (13). However, such elevations in right heart pressure may alter the flow direction through a PFO and potentially lead to paradoxical embolism (14).

Given the high incidence of PFO in general population (up to 34%) and its association with stroke in the young (8,15–17), it is important to know the safety of endovascular declotting procedures in patients with a history of untreated PFO. There are only a few case reports of paradoxical emboli secondary to endovascular declotting procedure for thrombosed AVFG (14,18,19). It is hypothesized that such a low incidence of paradoxical embolic events in these patients is secondary to a low incidence of right to left shunt or intermittent nature of the shunt with low volume of blood being transferred (16,20). Similar to the reported studies, our study documented no systemic embolic events during endovascular declotting procedures in patients with echocardiography confirmed PFO. The flow direction across the PFO had no influence in the occurrence of systemic embolic events.

Our study documented the safety of declotting procedures in patients with PFO. As such, patients undergoing declotting procedures may not necessitate a formal echocardiography to rule out the presence of PFO, although a large multi-center study is useful to confirm the preliminary findings of our study. In addition, whether such a recommendation can be applied for surgical thrombectomy needs further clinical studies.

The main limitations of our study are the retrospective nature and the small patient-sample size. Although a prospective trial with a larger number of patients would be highly useful, our study provided follow-up during multiple declotting procedures.

Conclusions

Endovascular declotting procedure of thrombosed arteriovenous grafts and arteriovenous fistulae in patients with PFO is safe and is rarely associated with any symptomatic paradoxical embolic events.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • Received November 5, 2010.
  • Accepted February 5, 2011.
  • Copyright © 2011 by the American Society of Nephrology

References

  1. ↵
    National Kidney Foundation-Dialysis Outcomes Quality Initiative: NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 30[Suppl 3]: S150–S191, 1997
    OpenUrlPubMed
  2. ↵
    1. Shurraw S,
    2. Zimmerman D
    : Vascular access complications in daily dialysis: A systematic review of the literature. Minerva Urol Nefrol 57: 151–163, 2005
    OpenUrlPubMed
  3. ↵
    National Kidney Foundation-Dialysis Outcomes Quality Initiative: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 37[Suppl 1]: S182–S238, 2001
    OpenUrlCrossRefPubMed
  4. ↵
    1. Trerotola SO,
    2. Johnson MS,
    3. Schauwecker DS,
    4. Davidson DD,
    5. Filo RS,
    6. Zhou XH,
    7. Eckert GJ,
    8. Dreesen RG,
    9. Carlson KA,
    10. Forney M
    : Pulmonary emboli from pulse-spray and mechanical thrombolysis: evaluation with an animal dialysis-graft model. Radiology 200: 169–176, 1996
    OpenUrlCrossRefPubMed
  5. ↵
    1. Weng FL,
    2. Berns JS
    : Complications of percutaneous treatment of thrombosed hemodialysis access grafts. Semin Dial 16: 257–262, 2003
    OpenUrlPubMed
  6. ↵
    1. Handke M,
    2. Harloff A,
    3. Olschewski M,
    4. Hetzel A,
    5. Geibel A
    : Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357: 2262–2268, 2007
    OpenUrlCrossRefPubMed
  7. ↵
    1. Di Tullio MR
    : Patent foramen ovale: Echocardiographic detection and clinical relevance in stroke. J Am Soc Echocardiogr 23: 144–155, quiz 220, 2010
    OpenUrlCrossRefPubMed
  8. ↵
    1. Lechat P,
    2. Mas JL,
    3. Lascault G,
    4. Loron P,
    5. Theard M,
    6. Klimczac M,
    7. Dobinski G,
    8. Thomas D,
    9. Grosgogeat Y
    : Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318: 1148–1152, 1988
    OpenUrlCrossRefPubMed
  9. ↵
    1. Lok CE
    : Fistula first initiative: Advantages and pitfalls. Clin J Am Soc Nephrol 2: 1043–1053, 2007
    OpenUrlFREE Full Text
  10. ↵
    1. Bush RL,
    2. Lin PH,
    3. Lumsden AB
    : Management of thrombosed dialysis access: Thrombectomy versus thrombolysis. Semin Vasc Surg 17: 32–39, 2004
    OpenUrlCrossRefPubMed
  11. ↵
    1. Middlebrook MR,
    2. Amygdalos MA,
    3. Soulen MC,
    4. Haskal ZJ,
    5. Shlansky-Goldberg RD,
    6. Cope C,
    7. Tentecost MJ
    : Thrombosed hemodialysis grafts: Percutaneous mechanical balloon declotting versus thrombolysis. Radiology 196: 73–77, 1995
    OpenUrlCrossRefPubMed
  12. ↵
    1. Smits HF,
    2. Van Rijk PP,
    3. Van Isselt JW,
    4. Mali WP,
    5. Koomans HA,
    6. Blankestijn PJ
    : Pulmonary embolism after thrombolysis of hemodialysis grafts. J Am Soc Nephrol 8: 1458–1461, 1997
    OpenUrlAbstract
  13. ↵
    1. Toosy K,
    2. Saito S,
    3. Patrascu C,
    4. Jean R
    : Cardiac arrest following massive pulmonary embolism during mechanical declotting of thrombosed hemodialysis fistula: Successful resuscitation with tPA. J Intensive Care Med 23: 143–145, 2008
    OpenUrlCrossRefPubMed
  14. ↵
    1. Briefel GR,
    2. Regan F,
    3. Petronis JD
    : Cerebral embolism after mechanical thrombolysis of a clotted hemodialysis access. Am J Kidney Dis 34: 341–343, 1999
    OpenUrlCrossRefPubMed
  15. ↵
    1. Hagen PT,
    2. Scholz DG,
    3. Edwards WD
    : Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59: 17–20, 1984
    OpenUrlCrossRefPubMed
  16. ↵
    1. Hara H,
    2. Virmani R,
    3. Ladich E,
    4. Mackey-Bojack S,
    5. Titus J,
    6. Reisman M,
    7. Gray W,
    8. Nakamura M,
    9. Mooney M,
    10. Poulose A,
    11. Schwartz RS
    : Patent foramen ovale: Current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46: 1768–1776, 2005
    OpenUrlCrossRefPubMed
  17. ↵
    1. Tobis MJ,
    2. Azarbal B
    : Does patent foramen ovale promote cryptogenic stroke and migraine headache? Tex Heart Inst J 32: 362–365, 2005
    OpenUrlPubMed
  18. ↵
    1. Yu AS,
    2. Levy E
    : Paradoxical cerebral air embolism from a hemodialysis catheter. Am J Kidney Dis 29: 453–455, 1997
    OpenUrlPubMed
  19. ↵
    1. Owens CA,
    2. Yaghmai B,
    3. Aletich V,
    4. Benedetti E,
    5. Ecanow J,
    6. Warner D
    : Fatal paradoxic embolism during percutaneous thrombolysis of a hemodialysis graft. Am J Roentgenol 170: 742–744, 1998
    OpenUrlCrossRefPubMed
  20. ↵
    1. Foster PP,
    2. Boriek AM,
    3. Butler BD,
    4. Gernhardt ML,
    5. Bove AA
    : Patent foramen ovale and paradoxical systemic embolism: a bibliographic review. Aviat Space Environ Med 74: B1–B64, 2003
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 6 (6)
Clinical Journal of the American Society of Nephrology
Vol. 6, Issue 6
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Paradoxical Embolism after Declotting of Hemodialysis Fistulae/Grafts in Patients with Patent Foramen Ovale
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Paradoxical Embolism after Declotting of Hemodialysis Fistulae/Grafts in Patients with Patent Foramen Ovale
Steven Wu, Iftikhar Ahmad, Sohail Qayyum, Stephan Wicky, Sanjeeva P. Kalva
CJASN Jun 2011, 6 (6) 1333-1336; DOI: 10.2215/CJN.09851110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Paradoxical Embolism after Declotting of Hemodialysis Fistulae/Grafts in Patients with Patent Foramen Ovale
Steven Wu, Iftikhar Ahmad, Sohail Qayyum, Stephan Wicky, Sanjeeva P. Kalva
CJASN Jun 2011, 6 (6) 1333-1336; DOI: 10.2215/CJN.09851110
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
  • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
  • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
Show more Original Articles

Dialysis

  • Cardiac Geometry in Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network (IPPN) Registry
  • Geographic and Educational Factors and Risk of the First Peritonitis Episode in Brazilian Peritoneal Dialysis Study (BRAZPD) Patients
  • Defining Left Ventricular Hypertrophy in Children on Peritoneal Dialysis
Show more Dialysis

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire